Page 24 - HIVMED_v21_i1.indb
P. 24

Page 6 of 8  Guideline


              TABLE 2: Infant HIV post-exposure prophylaxis given at birth.
              Risk category              Indications                       Infant prophylaxis
              •   Low-risk infant at birth, whether breastfed  •  Maternal VL at delivery < 1000 copies/mL  •  Infant NVP at birth and then daily for six weeks
               or exclusively formula fed
              •   High-risk infant at birth in the breastfed   •  Mother not on ART at delivery, or  •   Infant NVP for a minimum of 12 weeks. Infant NVP only discontinued
               infant                                                        after confirmation of maternal VL being < 1000 copies/mL, and or
                                         •   Mother on ART with HIV VL ≥ 1000 copies/mL at delivery,   until four weeks after cessation of all breastfeeding.
                                          or prior to 12 weeks
                                         •   No HIV VL result available at delivery or prior to 12 weeks  •  Infant AZT twice daily for six weeks
              •   High-risk infant at birth in the infant   •  Mother not on ART at delivery, or  •   Infant NVP at birth and then daily for six weeks (provided that
               exclusively formula fed from birth                            avoiding breastfeeding is documented and sustained), and
                                         •   Mother on ART with HIV VL ≥ 1000 copies/mL at delivery,
                                          or prior to 12 weeks             •  Infant AZT twice daily for six weeks
                                         •   No HIV VL result available at delivery or prior to 12 weeks
              ART, antiretroviral therapy; AZT, zidovudine; NVP, nevirapine; VL, viral load; HIV, human immunodeficiency virus.
              TABLE 3: Time points for routine HIV testing in HIV-exposed and HIV-unexposed   TABLE 4: HIV tests for initial and confirmatory testing in children according to
              children.                                             age: 2019 prevention of mother-to-child transmission guidelines.
              Timing and type of HIV test          HIV-  HIV-
                                                  exposed  unexposed   Age of child   Initial HIV test  Confirmatory HIV test
                                                  infants  infants  Below 18 months of age  HIV PCR test  HIV PCR test (or VL test)
              HIV PCR test at birth                 x     -         18–24 months      HIV Rapid/ELISA test  HIV PCR test
              HIV PCR test at age 10 weeks          x     -         Two years and older  HIV Rapid/ELISA test  HIV Rapid/ELISA test
              HIV PCR test at age six months (offer HIV testing for   x  -  ELISA,  enzyme-linked  immunosorbent  assay;  HIV,  human  immunodeficiency  virus;  PCR,
              documented HIV negative mothers or mothers with unknown   polymerase chain reaction; VL, viral load.
              HIV status)
              Age-appropriate HIV test at six weeks post-cessation of   x  -
              breastfeeding                                         An HIV antibody test (HIV rapid or ELISA [enzyme-linked
              HIV antibody test at age 18 months (rapid test or HIV ELISA)   x  x  immunosorbent assay] test) is used as a screening test above
              (universal testing)
              Age-appropriate HIV test at anytime the child is unwell  x  x  18 months of age. However, in a small percentage of children
              If any HIV test is positive, the diagnosis is confirmed with a   x  x  the maternal  antibodies  persist  beyond  18 months  of  age,
              repeat HIV test (see guidelines below in Table 4) , and ART is   potentially  resulting  in  false-positive  HIV  diagnoses  and
              initiated immediately.
                                                                    inappropriate initiation of lifelong  ART.  Therefore, HIV
                                                                                                     22
              ART,  antiretroviral  therapy;  ELISA,  enzyme-linked  immunosorbent  assay;  HIV,  human
              immunodeficiency virus; PCR, polymerase chain reaction; VL, viral load.  PCR testing is now recommended as confirmatory testing in
                                                                    all HIV-positive HIV rapid or ELISA tests in children under
              with any child immunisation visit. Instead, all HIV-exposed   two years of age. A summary of initial and confirmatory HIV
              infants, both low and high risk, are to receive an HIV PCR test   testing is outlined in Table 4.
              at the six-month integrated well-child visit. Over 80% of
              infants who acquire HIV do so by six months of age,   At the clinician’s discretion, the HIV PCR may be replaced by
              highlighting the importance of this six-month HIV PCR test.    a VL test, which has the advantage of both confirming the
                                                             8
              However, the risk of infant HIV acquisition may shift to more   HIV diagnosis and providing a baseline VL for monitoring
              than 20% after six months of age if longer periods of   the child’s response to  ART. Diagnostic difficulties, for
              breastfeeding are achieved. Breastfed infants who test HIV   example indeterminate HIV PCR test results, require urgent
              negative, particularly those on antiretroviral prophylaxis,   expert advice.
              should not be assumed to be uninfected until after the age-
              appropriate post-weaning HIV test has been performed.
                                                                    Breastfeeding
              At six months of age, the HIV status of all infants not already   Due to the expanded access to  ART in South  Africa, the
              known to be HIV-exposed should be established by offering   country-level recommendations for breastfeeding are now
              an HIV test to the mother. This maternal HIV test should fall   the same whether or not the mother is living with HIV. 15,28
              into the routine three-monthly HIV testing schedule for all   These recommendations include exclusive breastfeeding for
              breastfeeding mothers who are not yet known to be living   the first six months, the introduction of appropriate
              with HIV. If a maternal HIV test is not feasible, consent should   complementary foods thereafter, and continued breastfeeding
              be obtained to perform a rapid test on the child. Care that is   for two years or longer. Given the numerous benefits of
              provided in an integrated manner to the mother-infant pair   breastfeeding for the health and well-being of all children, it
              greatly facilitates this process of (1) identifying a women as   is imperative that mothers are supported to breastfeed their
              breastfeeding, (2) identifying those women who require HIV   infants for the longest possible duration whilst maintaining
              testing, and (3) determining the care required by the infant as   viral suppression and reducing the risk of HIV-transmission
              informed by the mother’s results. Breastfeeding mothers who   through breastmilk exposure.
              are not receiving integrated care face a significant challenge
              with regard to repeat HIV testing. Much will need to be done   To reduce HIV transmission during breastfeeding, the guideline
              to ensure that breastfeeding mothers are able to access HIV   outlines two major strategies. The first is to improve viral
              testing services within family planning clinics and other   suppression rates in the period after birth by (1) providing
              general health services, and that her infant receives the   potent and well-tolerated ART regimens – including DTG,
              appropriate care according to her test results.       (2) outlining mechanisms  for  linking  mothers back  into


                                           http://www.sajhivmed.org.za  16  Open Access
   19   20   21   22   23   24   25   26   27   28   29